Understanding the symptoms of cirrhosis can facilitate early diagnosis and intervention, improving outcomes for those ...
On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study ...
Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC ...
50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...
Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure.Two participants who ...
Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared to other cohorts assessed previously23% of participants ...
Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...
Medically reviewed by Oliver Eng, MD Alanine aminotransferase (ALT) is an enzyme primarily found in your liver. An enzyme is ...
Among the younger patients, liver transplants increased tenfold ... They also could not account for the potential influence ...
Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...